All News

Children diagnosed with embryonal brain tumors who have experienced treatment-related hearing loss exhibited greater difficulties reading – in particular, with phonological skills and processing speed, according to study results.

The V Foundation for Cancer Research and ESPN Hall of Fame Sportscaster Dick Vitale are pleased to announce the 14th Annual Dick Vitale Gala raised more than $4.3 million for pediatric cancer research.

A good nurse can make a huge difference for a patient struggling to deal with an illness, not only in comfort, or pain relief, or even in teaching how to manage symptoms or side effects – but in hope and confidence.

The Prostate Cancer Foundation announced the newly revised 2019 Prostate Cancer Patient Guide, a comprehensive resource for diagnosis, treatment, side effects, survivorship, and risk factors for patients and families with a history of prostate cancer.

A breast cancer survivor remembers an inconvenient Mother’s Day phone call as he celebrates five years of being cancer-free.

The Food and Drug Administration approved Cyramza for certain patients with hepatocellular carcinoma.

From National Women's Health Week to today’s top athletes, here’s what’s making headlines in the cancer space this week.

With the growing price of cancer treatment, researchers evaluated the cost-effectiveness of the new standard-of-care in frontline metastatic renal cell carcinoma.

The phase 3 CheckMate 498 trial, designed to compare Opdivo with Temodal for the treatment of patients with newly diagnosed O6-methylguanine-DNA methyltransferase (MGMT)-unmethylated glioblastoma multiforme failed to meet its primary endpoint of increasing overall survival.

A second ovarian cancer recurrence in three years prompted this review of lessons learned. If I could go back three and a half years and give advice to my newly diagnosed self, what would I say?

Treatment with bb2121 showed promising efficacy and safety among heavily pretreated patients with multiple myeloma, according to interim results published in the New England Journal of Medicine.

How does attitude affect a diagnosis of cancer? Does a positive attitude prolong a person’s life? Does a negative attitude make cancer grow? This survivor discusses how attitude affects cancer in a person’s life.

The Bruton tyrosine kinase inhibitor showed a statistically-significant and clinically-meaningful improvement in progression-free survival in patients with previously-treated CLL.

At 42,000 US deaths a year, the push to call metastatic breast cancer "chronic" is premature.

A generous donor will match every donation up to $100,000 to the Tyler Trent Fund.

Funds raised to support cancer research in Virginia, nationwide.

Vision Boards are both therapeutic and fun for cancer survivors and everyone else!

The FDA approved Kadcyla for adjuvant treatment of patients with HER2-positive early breast cancer who have residual invasive disease after neoadjuvant taxane and Herceptin-based treatment.

From an FDA decision to keep textured breast implants on the market to TV personalities and politicians, here’s what’s making headlines in the cancer space this week.

Lack of awareness and knowledge of early-onset colorectal cancer is a problem, but early messaging can help combat the issue.

Surveillance guidelines for hereditary colorectal cancer may be more effective in preventing the disease compared with those intended for individuals with a family history.

The FDA has approved a supplemental new drug application for Tibsovo as a single agent for the first-line treatment of adult patients with IDH1-mutant acute myeloid leukemia who are 75 years and older or are ineligible to receive intensive chemotherapy.

Stuck in his own fear. How needle-phobia kept this cancer survivor pinned down.

Walgreens expands health and beauty support program for patients with cancer.

There are currently more than 700 new therapies in development for people with cancer, representing a trend that is being driven by increased innovation.

More and more patients are being offered palliative, or supportive, care, and this is a welcomed trend.

Here are the top 5 CURE stories for April 2019.

Researchers examined the prevalence of chronic opioid use among survivors of breast, colorectal and lung cancer.